• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

July 24, 2019

View Archived Issues

Novel gamma-secretase modulators with potent in vitro and in vivo activity

Read More

DNAH17 heavy chain mutations in outer dynein arm are responsible for isolated male infertility

Read More

Researchers describe cell device for pancreatic islet transplantation without immunosuppression

Read More

PROTAC design approach for targeted degradation of BAP complex ATPAses in cancer

Read More

Inhaled alprazolam suppresses epileptiform activity in photosensitive participants with epilepsy

Read More

Deglycosylation predicts anti-PD-1/PD-L1 therapeutic efficacy

Read More

COPD has autoimmune component

Read More

BXCL-501 meets primary endpoint in phase Ib study for agitation associated with schizophrenia

Read More

Favorable safety data announced for dose-escalation run-in of phase III INTACT study

Read More

Marinus Pharmaceuticals presents data from Magnolia and Amaryllis phase II studies

Read More

Samus Therapeutics announces the launch of PU-AD clinical program

Read More

Characterization of novel RORgamma inhibitors for the treatment of autoimmune disease

Read More

Translocator protein as a microglia activation marker in early-stage AD and DLB

Read More

XC101-D13H as a promising new clinical-stage drug for the prevention of migraine

Read More

St. Jude Children's Research Hospital, CoA Therapeutics patent pantothenate kinase 3 inhibitors

Read More

New pantetheinase inhibitors discovered at Inception IBD

Read More

Nearmedic Plus describes asymmetric gossypol derivatives

Read More

BioMarin Pharmaceutical identifies hydroxyacid oxidase 1 inhibitors

Read More

GlycoMimetics discloses bifunctional inhibitors of E-selectin and galectin-3

Read More

Servier reports preclinical data on S-68890, a unique alpha7 nAChR allosteric modulator

Read More

Regulus outlines FDA requirements to reinitiate MAD studies with RGLS-4326

Read More

FDA approves rituximab biosimilar Ruxience

Read More

French ANR grant supports research to identify new targets of interest expressed by myeloid cells

Read More

Synairgen updates phase II progress with inhaled IFN-beta in patients with COPD

Read More

Gilead presents data on TLR7 agonists vesatolimod and GS-986

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 5, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 5, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 3, 2025
  • DNA mutations or genetic disorder concept art

    Regenxbio’s Duchenne gene therapy data positive as shares falter

    BioWorld
    Regenxbio Inc.’s gene therapy in treating Duchenne muscular dystrophy (DMD) produced positive initial phase I/II results from its first five patients. However,...
  • Woman holding neck

    Merus combo trounces Keytruda in head-and-neck phase II

    BioWorld
    Investor hopes rose sharply for Merus NV’s phase III trials – data should roll out next year – with bispecific antibody petosemtamab after mid-stage results...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe